Cellsorba

Therapeutic Apheresis

Volumn 7, Issue 1, 2003, Pages 44-47

  Shibata, Hiroshi ^a   Kuriyama, Toshiji ^a   Yamawaki, Naokuni ^a  

^a Asahi Kasei Medical Co   (Japan)

Author keywords

Leukocytapheresis; Ulcerative colitis

Indexed keywords

ARTICLE; AUTOIMMUNE DISEASE; BLOOD FILTER; DEVICE; ENTERITIS; EXTRACORPOREAL CIRCULATION; INFLAMMATORY DISEASE; JAPAN; LEUKOCYTE; NATIONAL HEALTH INSURANCE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; ULCERATIVE COLITIS;

ARTHRITIS, RHEUMATOID; EQUIPMENT DESIGN; EQUIPMENT SAFETY; HUMANS; LEUKAPHERESIS; MICROPORE FILTERS; MICROSCOPY, ELECTRON; RANDOMIZED CONTROLLED TRIALS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 0037765015     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-0968.2003.00009.x     Document Type: Article

References (20)

1. Morse EE, Carbone PP, Freireich EJ, Bronson W, Kliman A. Repeated leukapheresis of patients with chronic myelocytic leukemia. Transfusion 1966;6:175-82.
2. Buckner D, Graw RG Jr, Eisel RJ, Henderson ES, Perry S. Leukapheresis by continuous flow centrifugation (CFC) in patients with chronic myelocytic leukemia (CML). Blood 1969;33:353-69.
3. Curtis JE, Hersh EM, Freireich EJ. Leukapheresis therapy of chronic lymphocytic leukemia. Blood 1972;39:163-75.
4. Pearson CM, Paulus HE, Machleder HI. The role of the lymphocyte and its products in the propagation of joint disease. Ann NY Acad Sci 1975;256:150-68.
5. Tsuda H, Yokoyama M, Sato M, Yamagata J, Hashimoto H, Hirose S. Lymphocytapheresis and lymphocytoplasmapheresis in the treatment of systemic lupus erythematosus. Jpn J Artif Organs 1986;15:1637-40.
6. Takenaka Y. Recent development of leukocyte separation materials and their future. Jpn J Apheresis 1995;14:17-18.
7. Takenaka Y. Lymphocytapheresis. Artif Organs 1996;20:914-16.
8. Suemitsu J, Yoshida M, Yamawaki N, Yamashita Y. Leukocytapheresis therapy by extracorporeal circulation using a leukocyte removal filter. Ther Apheresis 1998;2:31-6.
9. Shirokaze J. Leukocytapheresis using a leukocyte removal filter. Ther Apher 2002;6:261-6.
10. Matsuda T, Isumihara T, Gotanda M, Niimura T. Lymphocytapheresis using leukocyte removal column (Cellsorba) for treatment of rheumatoid arthritis. In: Oda T, ed. Therapeutic Plasmapheresis, Cleveland: ISAO Press, 1988;73-8.
11. Hashimoto H. Lymphocytapheresis and lymphocyteplasmapheresis in SLE. Med Immunol 1985;10:61-8.
12. Sunny D. Leukodepletion blood filters. Transfus Med Rev 1993;12:65-77.
13. Sunny D. Mechanism of leukocyte removal by filtration. In: Lane TA, Myllyla G, eds. Leukocyte-depleted Blood Products (Current Studies in Hematologic Blood Transfusion, no. 60). Basel: Karger, 1994;123-33.
14. Sugi K. Filtration leukocytapheresis expected to ulcerative colitis treatment. BIO Clinica 1997;12:339-42.
15. Daibutsu M, Takagi T, Ogawa H et al. Treatment of chronic rheumatoid arthritis by lymphocytapheresis. Ther Plasmapheres 1987;7:257-60.
16. Kondoh T, Hidaka Y, Katoh H, Inoue N, Saito S. Evaluation of a filtration lymphocytapheresis (LCP) device for use in the treatment of patients with rheumatoid arthritis. Artif Organs 1991;15:180-8.
17. Hidaka T, Suzuki K, Matsuki Y et al. Filtration leukocytapheresis therapy in rheumatoid arthritis. A randomized, double blind, placebo-controlled trial. Arthritis Rheum 1999;42:431-7.
18. Sawada K, Ohnishi K, Kosaka T et al. Leukocytapheresis therapy with leukocyte removal filter for inflammatory bowel disease. J Gastroenterol 1995;30(Suppl.):124-7.
19. Sawada K, Muto T, Shimoyama T et al. Multicenter randomized controlled trial for the treatment of ulcerative colitis with a leukocytapheresis column. Curr Pharm Des 2003;9:in press.
20. Fukunaga K, Sawada K, Fukuda Y et al. A case report: First case of filtration leukocytapheresis for a patient of aortitis syndrome associated with ulcerative colitis. Ther Apheresis 2002;6:93-8.